Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q3 FY262026-06-26 | Q2 FY262026-03-27 | Q1 FY262025-12-26 | Q4 FY252025-09-26 | Q3 FY252025-06-27 | Q2 FY252025-03-28 | Q1 FY252024-12-27 | Q4 FY242024-09-27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $305.00M | $395.63M | $346.71M | $307.02M | $315.55M | $369.56M | $357.00M | $304.81M |
| Cost of revenue | $40.32M | $44.73M | $43.21M | $39.52M | $44.00M | $35.84M | $40.77M | $34.00M |
| Gross profit | $264.68M | $350.90M | $303.50M | $267.51M | $271.54M | $333.72M | $316.23M | $270.81M |
| Gross margin | 86.8% | 88.7% | 87.5% | 87.1% | 86.1% | 90.3% | 88.6% | 88.8% |
| Research and development | $65.75M | $63.65M | $69.08M | $67.47M | $65.98M | $61.71M | $66.64M | $68.64M |
| Selling, general and administrative | $160.66M | $172.12M | $161.80M | $164.24M | $158.47M | $160.04M | $164.49M | $157.11M |
| Operating expenses | $230.36M | $237.95M | $241.34M | $237.83M | $223.91M | $225.96M | $236.35M | $224.46M |
| Operating income | $34.32M | $112.95M | $62.16M | $29.68M | $47.64M | $107.76M | $79.88M | $46.35M |
| Operating margin | 11.3% | 28.5% | 17.9% | 9.7% | 15.1% | 29.2% | 22.4% | 15.2% |
| EBITDA | $60.87M | $139.23M | $96.77M | $57.80M | $69.02M | $133.51M | $107.46M | $66.42M |
| Interest income | $3.45M | $5.02M | $4.12M | — | $4.11M | $3.56M | $2.65M | — |
| Interest expense | $0 | $0 | $0 | $15.38M | $0 | $0 | $0 | $34.08M |
| Income before taxes | $43.80M | $119.70M | $71.60M | $41.67M | $55.52M | $120.25M | $86.05M | $59.73M |
| Income taxes | $14.59M | $24.25M | $17.92M | −$7.99M | $8.97M | $28.02M | $17.98M | $868.00K |
| Net income | $29.21M | $95.45M | $53.68M | $49.65M | $46.54M | $92.23M | $68.07M | $58.87M |
| Net margin | 9.6% | 24.1% | 15.5% | 16.2% | 14.7% | 25.0% | 19.1% | 19.3% |
| EPS, basic | $0.30 | $1.00 | $0.56 | $0.52 | $0.48 | $0.95 | $0.71 | $0.61 |
| EPS, diluted | $0.30 | $0.99 | $0.55 | $0.51 | $0.48 | $0.94 | $0.70 | $0.60 |
| Diluted shares | 94.52M | 95.52M | 96.52M | 97.48M | 96.90M | 97.47M | 97.15M | 97.33M |
Figures describe Dolby Laboratories shares, not any token. As of Jul 30, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.